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Summary. We consider joint selection of fixed and random effects in general low dimen-
sional nonlinear mixed-effects models setting which naturally occur in many applications
such as pharmacokinetics. We propose an iterative algorithm that is inspired from step-
wise regression strategies and that is based on a BIC model selection criterion whose
penalty is adapted to mixed-effects models. We demonstrate the robustness of the algo-
rithm in different simulated experiments and its practical benefits on the clinical study of
an antibiotic agent kinetics.
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1. Introduction
Nonlinear mixed effects models are widely used in studies where repeated measurements
are observed from several independent individuals, which is common in numerous dis-
ciplines such as pharmacology, medicine or agriculture. Nonlinear mixed effects models
can be viewed as extensions of standard nonlinear regression models in which random
effects are incorporated in the coefficients to take into account variations between in-
dividuals and correlations between observations from the same subject. We adopt the
hierarchical formalism of Pinheiro and Bates (2009) or Lavielle (2014) that includes a
very broad class of mixed-effects models in which the jth observation of ith subject is
modeled as
yij = f(ψi, xij) + εij , i = 1, . . . , N , j = 1, . . . , ni , (1)
where N is the number of subjects, ni is the number of observations on subject i and the
εij ’s are residual errors, often normally distributed. The function f can be nonlinear in
at least one component of the parameter ψi and the xij ’s are structural design variables
such as time tij and possible additional conditions under which individual i is observed
like drug dose in a pharmacological study for instance. In a mixed-effects model, the
same regression function f is used for the N individual series of observations, but each
individual has his own vector of parameter values ψi ∈ R
d. The individual parameter
vectors ψi are defined as independent Gaussian random variables such that:
g(ψi) = µ+ Ciβ + ηi , ηi ∼
i.i.d
N (0,Ω) (2)
2where Ci is a matrix of covariates for individual i, µ is the intercept, β ∈ R
q is a vector
of fixed effects and g is a link function. Ω = (ωkl)1≤k,l≤d is a d × d covariance matrix,
which is not necessarely diagonal for allowing the existence of correlations between the
model random effects ηi. Many examples of nonlinear mixed effects models can be found
in Lavielle (2014) or Pinheiro and Bates (2009).
A key issue in mixed effects modelling is accurately describing the different sources
of variability, including in particular the differences between individuals. In pharma-
cokinetic studies for example, it is crucial to identify the relevant covariates and random
effects. We reconsider the covariate and random effects model building of Burdet and al.
(2015) for the analysis of the kinetics of an antibiotic agent. In this study, patients re-
ceive a single infusion dose of Amikacin. The Amikacin blood concentration is then
measured at different times. The mixed effects model used in Burdet and al. (2015) for
describing the evolution over time of Amikacin concentration is based on the following
nonlinear regression function :
f(D, t, tD, Tinf , ψ) =
D
Tinf
[
A
α
(1− e−α(t−tD)) + B
β
(1− e−β(t−tD))
]
if t− tD ≤ Tinf
D
Tinf
[
A
α
(1− e−αTinf )e−α(t−tD−Tinf ) + B
β
(1− e−βTinf )e−β(t−tD−Tinf )
]
otherwise
(3)
where
A =
1
V1
α−Q/V2
α− β
; B =
1
V1
β −Q/V2
β − α
; α =
QCl
V1V2β
;
β =
1
2
Q
V1
+
Q
V2
+
Cl
V1
−
√(
Q
V1
+
Q
V2
+
Cl
V1
)2
− 4
Q
V2
Cl
V1
 .
The model parameter ψ = (Cl, V1, V2, Q) includes the Amikacin clearance Cl, the
central volume of distribution V1, the peripheral volume of distribution V2 and the inter-
compartmental clearance Q. Among the other quantities in (3), D refers to the total
amount of drug given to the patient, tD is time of drug administration, t is time of
measurement and Tinf is the time of infusion. In this model (D, tD, t, Tinf ) represent
the structural design variables named xij in equation (1) and are necessary to specify
properly the kinetics of the drug. Several covariates are measured for each patient
during the experiment : age, weight, gender, etc. One of the objectives of this work is
to characterize the pharmacokinetic variability between patients by properly linking the
measured covariates to the model parameters (Q,Cl, V1, V2) in the mixed effects model
framework given by (2). The identification of coherent random effects and covariate
structures is therefore a critical issue.
From a modelling point of view, the question is to determine if some of the variation
is purely random or if it is associated with known individual covariates Ci, which comes
down to determining the most appropriate covariance structure Ω for the random effects
together with the most relevant non null components of β. This is however a complex
issue since changing the structure of the random effects covariance matrix can lead to
different, sometimes irrelevant, selections of the covariates for the fixed effects. Moreover,
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including unnecessary random effects could lead to a near singular covariance matrix
that could be a problem for inference. Many contributions have tackled the question of
simultaneous selection of covariates and random effects in mixed-effects models in recent
years. For linear mixed models, Bondell et al. (2010) and Fan and Li (2012) proposed
modifications of LASSO procedures (Least Absolute Shrinkage and Selection Operator
(Tibshirani (1996)) with L1 penalties taken as a function of random effects. Within
the framework of generalized linear mixed models, Pan and Huang (2014), Chen et al.
(2015) and Schelldorfer et al. (2014) proposed LASSO type algorithms. These methods
heavily rely on the linear formalism of the models and are attractive when the number
of covariates is much larger than the total number of observations. The framework of
our study is a general non-linear parametric class of mixed models where the number
of covariates and the number of random effects is moderate with respect to the total
number of observations. To the best of our knowledge, only Bertrand and Balding (2013)
considered a broader class of nonlinear mixed-effects models. They compared bayesian
methods with Lasso and HyperLasso penalty methods, but their work was dedicated
to high dimensional settings for the covariates. In more standard finite dimensional
settings, there actually does not exist any clear consensus on model building for nonlinear
mixed effects models. Penalized likelihood criteria such as BIC (Bayesian Information
Criterion) are very popular in many fields of applications but the appropriate definition
of its penalty term was unclear until the work of Delattre et al. (2014). Moreover,
using BIC as a model selection tool suffers the drawback that the criterion needs to
be evaluated for any candidate model, which can be laborious when the number of
competing models is high. This is actually the case when one performs joint covariate
and random effects selection in mixed-effects models, even for moderate numbers of
covariates and moderate numbers of potential random effects. In this paper, we propose
a tractable solution for a broad range of nonlinear mixed models that works well in
practice with a moderate number of individual parameters and covariates. We have
designed an iterative method inspired from stepwise regression strategies. The procedure
relies on an appropriate BIC model selection criterion, whose theoretical properties have
been studied in Delattre et al. (2014). Note that step-down algorithms have ever been
implemeted for the specific context of linear mixed-effects models in the lmerTest R
package (Kuznetsova et al. (2017)), but the simplification procedure is based on testing
approaches that are much more difficult to reproduce in a nonlinear mixed effects model
setting (Baey et al. (2019)). The proposed algorithm is implemented in a R function
which is provided and fully documented in supplementary materials.
The organization of the paper is outlined as follows. The general procedure for
joint covariate and random effect selection is described in section 2. In section 3, a
simulation study is carried out to assess the capacity of the proposed method to identify
the appropriate covariates and random effects. The analysis of the real Amikacin data
42. Joint covariate and random effect selection procedure
2.1. Objective and approach
We want to tackle here the identification of the covariates and random effects that best
characterize the inter-individual variability in the nonlinear mixed effects model settings
of equations (1)-(2). We are given a sample of observations y = (yij)1≤i≤N,1≤j≤ni , co-
variates (ci)i=1,...,N and a model structure through a nonlinear regression fonction f . Not
necessarily all the components of ψi need to be random. The role of the random effects is
to describe the part of the variability between subjects that the covariates ci measured in
the sample would not be able to explain. Let us define the true covariate structure as the
set S0β =
{
k : β0k 6= 0, k = 1, . . . , q
}
which contains the indices of the true nonzero fixed
effects. As well, denote by S0Ω =
{
(k, k′) : ω0k,k′ 6= 0, k = 1, . . . , d ; k
′ = k, . . . , d
}
the true
covariance structure, that is the set of the positions of the true nonzero components of
the covariance matrix of the individual parameters. Then our goal is to find out S0β and
S0Ω simultaneously from the sampled data. When the model includes d individual pa-
rameters and p covariates that are measured for each individual, there are 2p×d possible
covariate structures Ciβ to which must be added 2
p possible random effects structures.
The number of competing models is therefore huge, even for moderate values of d and
p, and hence an exhaustive model selection is not possible in a reasonable time frame.
At the present time, there does not exist any clear consensus on how to deal with such
model selection issue in nonlinear mixed-effects models. The way to efficiently combine
covariate and random effects selection and the choice of an adequate criteria for selec-
tion remain open questions in nonlinear mixed-effects models. We suggest an iterative
method which alternates two steps
(a) a research of the influent covariates aiming at estimating S0β by using a stepwise
approach,
(b) an exhaustive review of the random effects structure aiming at refining the estima-
tion of S0Ω given the current estimation of S
0
β.
Each step of the procedure is performed by optimizing a BIC. The estimated model
structures Ŝ0β and Ŝ
0
Ω are then the model structures that were chosen at the last iteration
of the procedure.
As shown in Delattre et al. (2014), people must be carefull with the definition of
BIC in mixed effects models since the parameters are not all penalized the same way.
According to the step of the procedure, we need a good definition of BIC when selecting
covariates for a given and fixed covariance structure of the random effets (step 1), and an
appropriate definition of BIC when selecting the covariance structure of the random effets
when the covariate structure is known (step 2). The first was given in Delattre et al.
(2014) and the second can be straightforwardly obtained by following the same lines of
proof than in Delattre et al. (2014).
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2.2. Model comparison via BIC
2.2.1. Adequate partition of the model parameters
The result of Delattre et al. (2014) relies on a specific partition of the parameters. The
idea is to use a degenerate model formulation induced by reordering the individual
parameters according to the covariance structure SΩ of the model. More precisely,
the idea is to isolate the components of ψi that are random, ψR,i, from the ones that
are not random, ψF,i. The components ψR,i correspond to diagonal positions (k, k),
k = 1, . . . , d, which belong to SΩ, whereas the components ψF,i correspond to diagonal
positions (k, k), k = 1, . . . , d that do not belong to SΩ. If ψF,i is not empty, Ω is singular
and can be written as Ω = diag(0,ΩR), where ΩR is the covariance matrix of the ψR,i,
thus invertible.
This decomposition of the individual parameters induces a particular decomposition
of the fixed effects and of the population parameters. Indeed, writting
ψi =
(
ψF,i
ψR,i
)
, Ci =
(
CF,i 0
0 CR,i
)
, ηi =
(
ηF,i
ηR,i
)
,
we get
β =
(
βF
βR
)
, θ =
(
θF
θR
)
, (4)
where θR = (βR, vec(ΩR)), θF = βF and vec(SΩ) is the set of non zero elements of ΩR.
2.2.2. Appropriate BIC penalties
We denote ℓ(y; θˆ) the log-likelihood of the observations evaluated at the maximum like-
lihood estimate θˆ of θ. We have the following results.
Proposition 1. Assume that the covariance structure SΩ of the model is given, then
the appropriate BIC expression for covariate selection is given by:
BIC = −2ℓ(y; θˆ) + dim(βR) logN + dim(βF ) log ntot, (5)
where βR and βF are given by the parameter partition induced by the covariance structure
SΩ (see section 2.2.1), N is the number of subjects and ntot =
∑N
i=1 ni is the total number
of observations.
Proposition 2. Assume that the covariate structure Sβ is given, then the appropri-
ate BIC expression for selecting the random effects structure is given by:
BIC = −2ℓ(y; θˆ) + dim(SΩ) log(N), (6)
where dim(SΩ) denotes the number of non zero elements of the covariance matrix Ω.
Remarks:
(a) Proposition 1 has been derived in Delattre et al. (2014) and proposition 2 can be
straightforwardly obtained by using similar lines of proof than in Delattre et al.
(2014). Refer to Delattre et al. (2014) for technical details.
6(b) Computing θˆ and ℓ(y; θˆ) are difficult problems in practice in many nonlinear mixed-
effects models. Indeed, as the random effects ηi are not observed, the expression of
ℓ(y; θ) involves integrals over the distributions of the ψi that often don’t have any
closed form expression:
ℓ(y; θ) = log
[
N∏
i=1
∫
p(yi|ψi)p(ψi; θ)dψi
]
.
Nevertheless, many methods have been developed to estimate the model parameters
and to compute approximations of ℓ(y; θˆ). These are mostly implemented in the
different software packages dealing with mixed models.
2.3. The selection algorithm
Propositions 1 and 2 give the appropriate criterions to be optimized in the two steps
of the procedure. Starting from a preliminary inclusion step, the algorithm consists of
alternating selection of random effects and selection of covariates through inclusion and
exclusion steps. It returns the two model structures Ŝ0β and Ŝ
0
Ω. These different steps
are now described.
(a) (i) Selection of the random effects structure
First start with no covariates in the model:
ψi = µ+ ηi , i = 1, . . . , N. (7)
Assume that there are K possible random effects structures given respectively
by their covariance structures SkΩ, k = 1, . . . ,K. To each S
k
Ω corresponds a
covariance matrix ΩR,k. At this step, the best covariance structure is chosen
as
Ŝ
(0)
Ω = argmin
Sk
Ω
, k∈1,...,K
− 2ℓ(y, β = 0, Ω̂R,k) + dim(S
k
Ω) log(N)
(ii) Selection of covariates
Then consider that ηi ∼
i.i.d
N (0,Ω(0)) where Ω(0) is the covariance matrix which
corresponds to the covariance structure Ŝ
(0)
Ω selected at previous step. Com-
pare the Q models that can be obtained from (7) by entering one covariate:
ψi = µ+ Ciβ + ηi , ηi ∼
i.i.d
N (0,Ω(0))
where β contains only one non zero component. At this step, the best covariate
structure is chosen as
Ŝ
(0)
β = argmin
Skβ , k∈1,...,Q
− 2ℓ(y, βˆk , Ω̂(0)) + dim(βR,k) logN + dim(βF,k) log ntot
where (βR,k, βF,k) is the partition of the fixed effects that corresponds to co-
variate structure Skβ . Keep the covariate structure Ŝ
(0)
β for the next step of the
procedure.
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(b) Now start from model
ψi = µ+Ciβ
(0) + ηi (8)
where the non null components of β(0) are defined by Ŝ
(0)
β and
(i) Selection of the random effects structure: choose the best covariance
structure Ŝ
(1)
Ω from all the possible covariance structures for ηi in (8) according
to:
Ŝ
(1)
Ω = argmin
Sk
Ω
, k∈1,...,K
− 2ℓ(y, ˆβ(0), Ω̂R,k) + dim(S
k
Ω) log(N)
(ii) Selection of covariates: by considering that ψi = µ + Ciβ + ηi and ηi ∼
i.i.d
N (0,Ω(1)), choose the best covariate structure, Ŝ
(1)
β , by entering or removing
a covariate from (8):
Ŝ
(1)
β = argmin
Skβ , k∈1,...,Q
− 2ℓ(y, βˆk , Ω̂(1)) + dim(βR,k) logN + dim(βF,k) log ntot
(c) Repeat (i) and (ii) by either entering or removing a covariate and stop when no
more covariate can be justifiably entered or removed from the model according to
BIC, therefore leading to the final model.
The procedure can be initialized with a non empty covariate structure. However,
in some situations, starting with a too complex covariate model could compromise the
proper conduct of the method since the estimation methods for mixed effects models
can encounter numerical difficulties especially with overly complex models.
3. Simulations
We now investigate the performances and the robustness of the proposed stepwise pro-
cedure for joint covariate and random effects selection in mixed-effects models. We
implement it with the R software by using the saemix package for the estimation of
the parameters and the computation of the log-likelihoods. We use the following linear
mixed-effects model for the numerical experiments:
yij = ψi1x1ij + ψi2x2ij + ψi3x3ij + ǫij, (9)
where i = 1, . . . , N stands for the individual, j = 1, . . . , n denotes the index of the
jth observation for a given individual, x1ij , x2ij and x3ij are regression variables that
are part of the structural model, and ǫij ∼
i.i.d.
N (0, σ2). The individual parameters
ψi = (ψi1, ψi2, ψi3)
′ are defined as:
ψi = µ+Xiβ + ηi, (10)
8where ηi ∼
i.i.d.
N (0,Ω), µ is the intercept vector, Xi =
c
(1)
i c
(2)
i 0 0 0 0
0 0 c
(1)
i c
(2)
i 0 0
0 0 0 0 c
(1)
i c
(2)
i

is the matrix of covariates for individual i and β = (β1, β2, β3, β4, β5, β6)
′ is the vector of
coefficients for the covariates. For the sake of simplicity, we assume that Ω is diagonal
with variance terms denoted by (ω21 , ω
2
2 , ω
2
3).
Given a dataset simulated according to (9), (10), the model selection issue is to
identify among c
(1)
i and c
(2)
i the covariates that are truly influent on each component of
ψi and the components of ηi that are appropriately random.
We separate three sets of experiments. The goal is to investigate if one situation is
more favourable for selecting either the correct covariates or the correct random effects.
(a) Experiment 1. In the first one, we simulate data according to a model where few
covariates are influent and where the variance of the true random effects is high.
The true model is the following:
ψi1 = µ1 + β1c
(1)
i + η1i,
ψi2 = µ2 + β4c
(2)
i ,
ψi3 = µ3 + η3i.
In other terms, ψi1 depends on covariate c
(1)
i only and is random, ψi2 depends on
covariate c
(2)
i only and is not random and ψi3 does not depend on covariates but
is random. This corresponds to setting β2, β3, β5, β6 and ω
2
2 to zero. We set
µ1 = µ2 = µ3 = 0.5, β1 = β4 = 1 and ω
2
1 = 3, ω
2
3 = 2.
(b) Experiment 2. In the second one, the true model remains the same, but we simulate
one random effect with a very small variance. The fixed effects values remain the
same, but we set ω21 = 3 and ω
2
3 = 0.05.
(c) Experiment 3. Finally, we change the true model and we assume that all the
covariates have an effect on all individual parameters: The true model used for
simulating the data now assumes that the three individual parameters depend on
both covariates
ψi1 = µ1 + β1c
(1)
i + β2c
(2)
i + η1i,
ψi2 = µ2 + β3c
(1)
i + β4c
(2)
i ,
ψi3 = µ3 + β5c
(1)
i + β6c
(2)
i + η3i.
As above, only ψi1 and ψi3 are random. We use the following values for the pa-
rameters: µ1 = µ2 = µ3 = 0.5, β1 = β2 = β3 = β4 = β5 = β6 = 1 and ω
2
1 = 0.6,
ω23 = 0.4.
For each experiment, we use different values for N and n leading to different sample
sizes: N = 20, n = 10, N = 100, n = 10, N = 20, n = 50 and N = 100, n = 50 and for
each value of (N,n), 100 datasets are simulated. The covariates c
(1)
i and c
(2)
i and the
regression variables x1ij , x2ij and x3ij are randomly drawn for each replicate according
Joint selection covariate and random effect selection in nonlinear mixed effects models 9
Table 1. Experiment 1: two covariates and high variance random effects. Percentage of
correct covariate structure selection (%C), percentage of correct random effects structure
selection (%R) and percentage of correct joint covariate and random effects structure selec-
tion (%correct) for different sample sizes (N,n) and different initilisations of the procedure.
Stepwise started without covariates Stepwise initialized at random
N,n % correct % C % R % correct % C % R
N = 20, n = 10 0.68 0.68 0.99 0.67 0.67 0.99
N = 20, n = 50 0.71 0.71 1 0.71 0.71 1
N = 100, n = 10 0.87 0.87 0.99 0.88 0.88 1
N = 100, n = 50 0.92 0.93 0.99 0.92 0.93 0.99
Table 2. Experiment 2: two covariates and one small variance random effect. Percentage
of correct covariate structure selection (%C), percentage of correct random effects structure
selection (%R) and percentage of correct joint covariate and random effects structure selec-
tion (%correct) for different sample sizes (N,n) and different initilisations of the procedure.
Stepwise started without covariates Stepwise initialized at random
N,n % correct % C % R % correct % F % R
N = 20, n = 10 0.62 0.76 0.82 0.61 0.75 0.82
N = 20, n = 50 0.69 0.69 1 0.69 0.69 1
N = 100, n = 10 0.88 0.88 1 0.88 0.88 1
N = 100, n = 50 0.94 0.94 1 0.94 0.94 1
to: x1ij ∼
i.i.d.
= U(−3, 3), x2ij ∼
i.i.d.
= U(−2, 2), x3ij ∼
i.i.d.
= U(−2.5, 2.5), c
(1)
i ∼
i.i.d.
= U(−5, 5)
and c
(2)
i ∼
i.i.d.
= U(−3, 3). For each simulated dataset, we keep the results obtained when
the procedure starts without any covariate in the model and when the procedure starts
with a covariate structure randomly chosen.
The results are given in tables 1, 2, 3 for experiments 1, 2 and 3 respectively. The
percentage of correct covariate structure selection (%C), the percentage of correct ran-
dom effects structure selection (%R) and the percentage of correct joint covariate and
random effects structure selection (%correct) are reported.
Table 3. Experiment 3: a large number of covariates. Percentage of correct covariate
structure selection (%C), percentage of correct random effects structure selection (%R) and
percentage of correct joint covariate and random effects structure selection (%correct) for
different sample sizes (N,n) and different initilisations of the procedure.
Stepwise started without covariates Stepwise initialized at random
N,n % correct % C % R % correct % C % R
N = 20, n = 10 0.99 1 0.99 0.99 1 0.99
N = 20, n = 50 1 1 1 1 1 1
N = 100, n = 10 0.99 1 0.99 0.99 1 0.99
N = 100, n = 50 1 1 1 1 1 1
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For each experiment, we see that the performances of the stepwise procedure improve
when the sample size increases. This is coherent since BIC is an asymptotic criterion for
model selection. Moreover, there is very little difference between the results obtained
when the procedure starts without any covariate in the model and when the procedure
starts with a covariate structure chosen at random. This shows that the procedure
is not sensitive to the starting point. This point is also illustrated in the full model of
experiment 3 where the correct model is found most of the time even when the procedure
starts with the empty covariate model which is very far from the true model. The three
experimental scenarios together show that recovering the covariate structure is more
difficult when the part of the variability due to the random effects is high, ie when the
signal to noise ratio is low.
4. Real Data
We used the clinical pharmacology study published in Burdet and al. (2015). In this
study, 60 patients with ventilator-associated pneumonia (VAP) received a 20 mg/kg sin-
gle infusion dose of Amikacin. The Amikacin blood concentration was then measured
at different times. Twelve covariates were also measured for each patient during the
experiment, including the age, the sex, the total body weight, the PaO2/F iO2 ratio
which characterizes respiratory distress syndrome, the 4-h creatinine clearance. One of
the objectives of this work was to characterize the pharmacokinetic variability between
patients suffering from VAP. In Burdet and al. (2015), model building is based on a
procedure described in Lavielle and Mentre (2007) associating Wald tests and likelihood
ratio tests for covariate selection and BIC comparison for the selection of the covariance
structure of the random effects. This procedure is quite usually used in PK, but there
actually does not exist any clear consensus on model building in nonlinear mixed effects
models frameworks. We illustrate our procedure on this concrete example.
For describing the concentration of Amikacin, we use the two-compartments model
(3) presented in the introduction:
f(D, t, tD, Tinf , ψ) =
D
Tinf
[
A
α
(1− e−α(t−tD)) + B
β
(1− e−β(t−tD))
]
if t− tD ≤ Tinf
D
Tinf
[
A
α
(1− e−αTinf )e−α(t−tD−Tinf ) + B
β
(1− e−βTinf )e−β(t−tD−Tinf )
]
otherwise
where
A =
1
V1
α−Q/V2
α− β
; B =
1
V1
β −Q/V2
β − α
; α =
QCl
V1V2β
;
β =
1
2
Q
V1
+
Q
V2
+
Cl
V1
−
√(
Q
V1
+
Q
V2
+
Cl
V1
)2
− 4
Q
V2
Cl
V1
 .
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Here ψ = (Q,Cl, V1, V2), Cl is the Amikacin clearance, V1 is the central volume of dis-
tribution, V2 is the peripheral volume of distribution, and Q is the inter-compartmental
clearance.
The observations (yij, 1 ≤ j ≤ ni) of individual i are then modeled as follows:
yij = fij + (a+ b fij) ǫij,
where fij = f(Di, tij, tD,i, Tinf,i, ψi), xij = (Di, tij , tD,i, Tinf,i) are the regression vari-
ables, ψi are the PK (pharmacokinetic) individual parameters for patient i, and the resid-
ual errors ǫij are iid standard Gaussian random variables. Due to positivity constraints,
ψi are log-normal random variables, i.e. logψi is Gaussian, such that logψi = µ+Ciβ+ηi,
where ηi ∼
i.i.d
N (0,Ω) and Ci = C(ci) is the matrix of covariates for individual i.
We use the iterative procedure described above. To avoid numerical difficulties due
to model complexity and to the high number of available covariates, we chose to start
with the null covariate model. As the number of random effects structures for ψi is high,
we chose to restrict the stepwise model research to diagonal covariance matrices and
then tried to add some correlations between the random effects of the retained model
in a second step. We excluded the censored Amikacin data. As a consequence, we
didn’t exactly use the same data as in Burdet and al. (2015). In this study, N = 53
and ntot = 247. In order to allow model comparison a posteriori, Burdet’s model is
re-estimated based on this new dataset. Our model selection procedure led to a model
that includes only three random effects (parameter Q is not random) and no correlation
between the three random effects:
logCLi = µCL + βCL,cClCri + βCL,a agei + ηCL,i
log V1,i = µV 1 + βV 1,w wi + βV 1,P P/Fi + ηV 1,i
logQi = µQ + βQ,s sexi
log V2,i = µV 2 + βV 2,cClCri + ηV 2,i (11)
The main difference between our final model (model1) and the one retained in
Burdet and al. (2015) (model2) is that model1 includes more covariates and less ran-
dom effects than model2. Generally speaking in a mixed-effects model, the random
effects aim at describing the part of the inter-individual variability that cannot be ex-
plained by the observed covariates. Model1 is quite satisfactory in this sense. Indeed,
the included covariates allow to limit the complexity of the random effects structure
whereas in model2, the covariance matrix of the random effects is full. Table 4 summa-
rizes the covariate structures of model1 and model2. In this table, symbol ⋆ identifies
the significant covariates in model1 (see equation (11) above) and symbol • in model2.
For instance in model1, the absence of random effect on parameter Q can be explained
by the fact that covariate sex is significant to explain the between-subjects variability
of Q. Adding the other covariates in model1 led to zeroing the correlation coefficients.
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Table 4. Amikacin data: comparison
of the covariate structures of model1 (⋆)
and model2 (•).
ClCr age sex w P/F
CL ⋆ • ⋆
V1 ⋆ • ⋆ •
Q ⋆
V2 ⋆
Table 5. Amikacin data: model
comparison.
Model BIC
model1 1492.624
model2 1643.676
model3 1513.123
We can compare model1 and model2 with an intermediate model3 that combines
the random effects structure of model1 and the three covariates of model2. The BIC
values for the three models are given in Table 5. Model1 has the smallest BIC value.
Simplifying the random effects structure of model2 strongly reduces the BIC value. This
shows that Burdet and al. (2015) identified the most influent covariates but not the most
relevant random effects.
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